Susquehanna International Group, LLP Seres Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $173,352 - $400,760	-186,400 Reduced 87.55%	26,500 $37,000
Q3 2023 Nov 14, 2023	SELL	$2.33 - $5.07 $90,171 - $196,209	-38,700 Reduced 15.38%	212,900 $506,000
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $965,756 - $1.35 Million	206,800 Added 461.61%	251,600 $1.21 Million
Q1 2023 May 16, 2023	BUY	$4.95 - $6.09 $99,495 - $122,409	20,100 Added 81.38%	44,800 $254,000
Q4 2022 Feb 14, 2023	SELL	$5.09 - $9.05 $335,431 - $596,395	-65,900 Reduced 72.74%	24,700 $138,000

Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $162,400 - $334,080	46,400 Added 104.98%	90,600 $582,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $123,660 - $348,996	-45,800 Reduced 50.89%	44,200 $152,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $107,730 - $151,164	-17,100 Reduced 15.97%	90,000 $641,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $360,598 - $684,657	-59,900 Reduced 35.87%	107,100 $892,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $180,726 - $748,060	33,100 Added 24.72%	167,000 $1.16 Million
Q2 2021 Aug 11, 2021	BUY	$18.46 - $24.36 $94,146 - $124,236	5,100 Added 3.96%	133,900 $3.19 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $911,256 - $1.49 Million	-51,600 Reduced 28.6%	128,800 $2.65 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $4.37 Million - $7.1 Million	-188,100 Reduced 51.04%	180,400 $4.42 Million
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $1 Million - $7.72 Million	268,600 Added 268.87%	368,500 $10.4 Million
Q2 2020 Aug 14, 2020	SELL	$3.04 - $6.2 $134,064 - $273,420	-44,100 Reduced 30.63%	99,900 $476,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $424,566 - $771,264	-185,400 Reduced 56.28%	144,000 $577,000
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $717,059 - $2.31 Million	314,500 Added 2110.74%	329,400 $1.06 Million
Q1 2019 May 15, 2019	SELL	$4.83 - $7.21 $28,497 - $42,539	-5,900 Reduced 28.37%	14,900 $102,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $186,915 - $235,365	-25,500 Reduced 55.08%	20,800 $158,000
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $326,152 - $450,760	-47,200 Reduced 50.48%	46,300 $398,000
Q1 2018 May 15, 2018	BUY	$7.34 - $11.16 $48,444 - $73,656	6,600 Added 7.59%	93,500 $686,000
Q4 2017 Feb 14, 2018	BUY	$9.15 - $12.64 $627,690 - $867,104	68,600 Added 374.86%	86,900 $881,000
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $234,423 - $308,355	18,300	18,300 $294,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$16.6 Million
1.17% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$4.91 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.73M
Shares

$4.85 Million
0.0% of portfolio
Hudson Bay Capital Management LP Greenwich, CT

5.43M
Shares

$3.91 Million
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

2.13M
Shares

$1.54 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account